Medtronic acquiring SPR Therapeutics in $650m deal
Global healthcare technology and biomedical engineering company Medtronic is acquiring SPR Therapeutics, a medical technology company specialising in percutaneous peripheral nerve stimulation for chronic pain management. The transaction involves an upfront cash payment of approximately $650m for all outstanding equity. Expected to close in the first half of Medtronic’s fiscal year 2027, the deal reflects an ongoing commitment to building…